Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies

Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies

Thymoquinone (TQ), the main bioactive component of Nigella sativa, has been found to exhibit anticancer effects in numerous preclinical studies. Due to its multitargeting nature, TQ interferes in a wide range of tumorigenic processes and counteracts carcinogenesis, malignant growth, invasion, migrat...

Full description

Bibliographic Details
Main Authors: A.G.M. Mostofa, Md Kamal Hossain, Debasish Basak, Muhammad Shahdaat Bin Sayeed
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-06-01
Series:Frontiers in Pharmacology
Subjects:
thymoquinone
cancer treatment
adjuvant therapy
preclinical studies
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00295/full

Internet

http://journal.frontiersin.org/article/10.3389/fphar.2017.00295/full

Similar Items